
Opinions
Gordon Higgins, CA, MBA
Novelion
NVLN-T
DON'T BUY
Oct 10, 2000
$76.000
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.